Skip to content

Study · Not a test of the peptide alone · 2007

2 results

Formation of acylated growth hormone-releasing peptide-6 by poly(lactide-co-glycolide) and its biological activity.

Na DH, Lee JE, Jang SW, Lee KC

AAPS PharmSciTech8 Jun 2007Cited by 59 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking GHRP-6.

  1. 01AnimalNot a test of GHRP-6 aloneAnimal study (in vivo)Activity measurement

    In rats, acylated GHRP‑6 had much lower biological activity than intact GHRP‑6.

    In plain wordsIn rats, acylated GHRP‑6 had much lower biological activity than intact GHRP‑6.

    Peptide
    GHRP-6
    Outcome
    DecreaseBiological activity after acylation
    Study

    ratn: not reported in source

    Comparator
    Intact GHRP-6
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    The evaluation of the biological activity in rats showed that the acylated GHRP-6 had a much lower activity than the intact GHRP-6.

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

  2. 02LabNot a test of GHRP-6 aloneIn vitro (cell-free)Other

    In cell-free formulation tests, higher molecular weight PLGA produced higher levels of acylated GHRP‑6 than lower molecular weight PLGA.

    In plain wordsIn lab tests, higher molecular weight PLGA produced more acylated GHRP‑6 than lower molecular weight PLGA.

    Peptide
    GHRP-6
    Outcome
    IncreaseGHRP-6 acylation
    Study

    n: not reported in source

    Comparator
    Lower molecular weight PLGA
    Outcome group
    Formulation, delivery and stability · Pharmacology

    Source sentences

    Summary
    Higher levels of acylated GHRP-6 were produced with the higher molecular weight PLGA, which might be due to the slower degradation rate of the polymer.

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.